In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...

Novo Nordisk's weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Oral ivarmacitinib, administered 4 mg or 8 mg once daily, significantly induced hair regrowth at 24 weeks vs. placebo in ...

Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug ... alopecia, although that is likely to diminish now that an FDA-approved option is available. The new ...

Eli Lilly and Incyte's baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with results ...

A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of ...

In Houston, there is a new clinical trial for men who struggle with pattern hair loss (PHL), a genetic disorder also known as ...

When diagnosing drug-induced alopecia, a doctor will take a complete medical history that takes into account the following factors: any new medications that the person is taking, including over ...

Bempikibart demonstrated positive, durable responses among patients with severe to very severe alopecia areata, according to ...

Arcutis Biotherapeutics is advancing in alopecia areata and atopic dermatitis with ZORYVE. Learn why ARQT stock offers growth ...

Alopecia refers to hair loss and can affect the scalp, eyebrows, eyelashes, and other areas of the body. There are different types of alopecia including androgenetic alopecia, alopecia areata, anagen ...

Frontal fibrosing alopecia (FFA) is a highly distressing ... while exploring the potential of targeting ERAP1 with highly specific drugs as a new way of treating this condition.